(Q48453604)

11 February 2018

title

Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). (English)

1 reference

11 February 2018

0 references

0 references

11

1 reference

11 February 2018

author name string

Terrence Town

1

1 reference

11 February 2018

Martina Vendrame

2

1 reference

11 February 2018

Anant Patel

3

1 reference

11 February 2018

Daniel Poetter

4

1 reference

11 February 2018

Anthony DelleDonne

5

1 reference

11 February 2018

Takashi Mori

6

1 reference

11 February 2018

Robert Smeed

7

1 reference

11 February 2018

Fiona Crawford

8

1 reference

11 February 2018

Thomas Klein

9

1 reference

11 February 2018

Jun Tan

10

1 reference

11 February 2018

publication date

1 November 2002

1 reference

11 February 2018

Journal of Neuroimmunology

published in

1 reference

11 February 2018

volume

132

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

49-59

1 reference

11 February 2018

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

The role of B7 costimulation in T-cell immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

T-cell subsets (Th1 versus Th2).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900307-7

7 January 2021

10.1016/S0165-5728(02)00307-7

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018